MAGENTIQ-COLO is an AI based FDA cleared colonoscopy device which offers a significant increase in Adenoma Detection Rate.
Current high rates of missed and undetected adenomas during colonoscopy means that even regularly screened patients are still at risk of developing colon cancer. A missed polyp can lead to interval cancer, which accounts for approximately 8% to 10% of all CRC in the U.S., translated to over 13,500 cancer cases that could be prevented every year with better detection.
A 2022 study of 950 patients at 10 hospitals showed that MAGENTIQ-COLO increasing ADR by 26% relatively, translating to a 21% decrease in CRC occurrence and a 35% decrease in patient mortality.